Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
NCT01581710
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Mild Persistent Asthma
Interventions
DRUG:
Montelukast to placebo
DRUG:
Placebo to montelukast
Sponsor
CHA University
Collaborators
[object Object]